An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort

Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

(2012) L. S. Magder et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Differences between Male and Female Systemic Lupus Erythematosus in a Multiethnic Population

(2012) T. C. TAN et al.   JOURNAL OF RHEUMATOLOGY

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Enhances the Ability of SLE Responder Index to Identify Responders in Clinical Trials

(2011) Z. TOUMA et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort

(2011) R. Lopez et al.   RHEUMATOLOGY

Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

(2011) M. B. Urowitz et al.   ARTHRITIS CARE & RESEARCH

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study

(2011) Mandana Nikpour et al.   ARTHRITIS RESEARCH & THERAPY

Medication Use in Systemic Lupus Erythematosus

(2010) S. BERNATSKY et al.   JOURNAL OF RHEUMATOLOGY

Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX

(2010) J. Zhang et al.   LUPUS

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Prednisone, Lupus Activity, and Permanent Organ Damage

(2009) M. THAMER et al.   JOURNAL OF RHEUMATOLOGY